SCHEMBL25001770

SCHEMBL25001770

CN1CCC(N2CCC(OI)CC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.36
▸ L3MBTL3 Q96JM7 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TLR9 Q9NR96 4/20 0.33
▸ TLR7 Q9NYK1 4/20 0.33
▸ HRH3 Q9Y5N1 2/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8158831 0.87 — —
SCHEMBL23158171 0.84 HRH3 (0.33) HRH3CYP2D6
SCHEMBL8266529 0.81 HRH3 (0.38) ALDH1A1L3MBTL3L3MBTL1TLR9TLR7
SCHEMBL23269640 0.77 L3MBTL1 (0.44) ALDH1A1L3MBTL3L3MBTL1HRH3NCF1
SCHEMBL14307143 0.77 L3MBTL1 (0.44) ALDH1A1L3MBTL3L3MBTL1HRH3NCF1
SCHEMBL26577467 0.77 L3MBTL3 (0.44) ALDH1A1L3MBTL3L3MBTL1HRH3CYP2D6
SCHEMBL26042916 0.77 L3MBTL3 (0.47) ALDH1A1L3MBTL3L3MBTL1NCF1
SCHEMBL1158533 0.76 CHRM1 (0.37) ALDH1A1L3MBTL3L3MBTL1TLR9TLR7
SCHEMBL1106428 0.76 ALDH1A1 (0.34) ALDH1A1L3MBTL3L3MBTL1TLR9TLR7
SCHEMBL25470943 0.76 ALDH1A1 (0.39) ALDH1A1L3MBTL3L3MBTL1TLR9TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback